Dauntless Investment Group, LLC Inmune Bio, Inc. Transaction History
Dauntless Investment Group, LLC
- $56.5 Million
- Q2 2025
A detailed history of Dauntless Investment Group, LLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Dauntless Investment Group, LLC holds 248,542 shares of INMB stock, worth $601,471. This represents 1.02% of its overall portfolio holdings.
Number of Shares
248,542
Previous 130,680
90.19%
Holding current value
$601,471
Previous $1.02 Billion
99.94%
% of portfolio
1.02%
Previous 1.19%
Shares
3 transactions
Others Institutions Holding INMB
# of Institutions
102Shares Held
6.32MCall Options Held
1.64MPut Options Held
3.35M-
Vanguard Group Inc Valley Forge, PA848KShares$2.05 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$1.97 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$1.44 Million45.87% of portfolio
-
Ubs Group Ag449KShares$1.09 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA390KShares$943,6330.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $43.4M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...